Susvimo is a unique therapeutic approach that provides continuous delivery of medicine to the eye through a refillable implant
Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret
Vabysmo PFS is the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal conditions that can cause blindness
Acquisition includes Restoret, a novel late-phase candidate for diabetic macular edema and neovascular age-related macular degeneration
The approval of YESAFILI marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the United States
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
Yesafili, received marketing authorization approval from the European Commission for the European Union
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway
The company has new projects in development in Mumbai, Punjab, central and northern India, among others
Subscribe To Our Newsletter & Stay Updated
